Franklin Resources
UBX

Franklin Resources’s Unity Biotechnology UBX Stock Holding History

Franklin Resources’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,567
Closed -$17.2K – 2768
2023
Q1 		$17.2K Hold
10,567
– – ﹤0.01% 2257
2022
Q4 		$29K Sell
10,567
-1
-0% -$3 ﹤0.01% 2255
2022
Q3 		$42K Buy
10,568
+4,302
+69% +$27.1K ﹤0.01% 2213
2022
Q2 		$35K Sell
6,266
-3,024
-33% -$25.2K ﹤0.01% 2277
2022
Q1 		$104K Hold
9,290
– – ﹤0.01% 2290
2021
Q4 		$136K Hold
9,290
– – ﹤0.01% 2301
2021
Q3 		$279K Buy
+9,290
New +$328K ﹤0.01% 2109

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Franklin Resources's UBX Position: Q2 2023 in Review

Franklin Resources sold out of Unity Biotechnology (UBX) in Q2 2023, closing a stake of 10,567 shares — an estimated $17.2K sold.

Franklin Resources first reported a position in UBX in Q3 2021 and held it in 7 quarters. The position peaked at $279K in Q3 2021. 40 funds tracked by Wall St. Rank hold UBX as of Q2 2023.

  • Franklin Resources reported no remaining Unity Biotechnology position as of Q2 2023 after selling out during the quarter.
  • Franklin Resources sold 10,567 Unity Biotechnology shares in Q2 2023, an estimated $17.2K.
  • Franklin Resources first reported a position in Unity Biotechnology in Q3 2021 and held it in 7 quarters.
  • Franklin Resources's Unity Biotechnology position peaked at $279K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2023.

Based on Franklin Resources's 13F filing for Q2 2023, filed 11 Aug 2023.